ALEAF - Aleafia Health rallies 17% following robust growth in core adult-use and medical cannabis product sales

Aleafia Health ([[ALEAF]] -16.6%) Q1 revenue of C$7.07M (-51.6% Y/Y).Net medical cannabis revenue of C$2.7M increased 95% Y/Y.Net adult-use cannabis was C$1.7M, compared to C$0.71M in Q1 2020 up 143% Y/Y and 22% Q/Q; Adult-use cannabis revenue in the first 41 days of Q2 2021 has surpassed total adult-use cannabis revenue for Q1 2021.Net bulk wholesale cannabis revenue was C$1.87M, a decline of 84% over the previous quarter, as previously disclosed in the Company’s fiscal year 2020 MD&A, domestic wholesale was expected to decline, relative to Q4 2020.Active, registered patients were 17,637 vs. 10,983 last year.Revenue per gram equivalent sold improved for the fourth consecutive quarter to C$8.46 vs. C$8.04 last year.Net loss of C$11.25M vs. C$6.16M in Q1 2020.Repayment of C$25.0M of convertible debt reduces the Company’s total debt by 43%.The company entered into an exclusive 10-year pact with Unifor, Canada’s largest private sector union, to support members securing medical cannabis insurance coverage. Recently, the Company launched the program to employees of

For further details see:

Aleafia Health rallies 17% following robust growth in core adult-use and medical cannabis product sales